Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.
from
  • AI use cases in the pharmaceutical and healthcare industries.
  • The risks and potentials of AI in GxP as well as non-GxP processes.
  • Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

More articles

The latest industry news, interviews, technologies and resources.

Addressing Challenges and Opportunities in Medical Writing Using AI

An interview with Dr. Richardus Vonk, Independent Advisor and Dr. Bertram Weiss, VP Health Vertical at Merantix Momentum.

AI Readiness in the Industrial Sector - Do's and Don'ts

To our first edition of "The AI Interview" series on AI Readiness in the Industrial Sector.

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Putting AI predictions into practice

An expert interview on the topic of AI-supported predictions.

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Data-driven to the drug of tomorrow

  • AI use cases in the pharmaceutical and healthcare industries.
  • The risks and potentials of AI in GxP as well as non-GxP processes.
  • Project report: supported document analysis for targeted identification of adverse drug reactions.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.

Discover more whitepapers

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Artificial Intelligence for Private Equity Portfolios

Increase in value for your entire portfolio

Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

Artificial Intelligence for Private Equity Portfolios

Increase in value for your entire portfolio

Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.